Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Cell Physiol ; 236(2): 1131-1147, 2021 02.
Artigo em Inglês | MEDLINE | ID: mdl-32643158

RESUMO

Since the outbreak of severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) in December 2019 in China, there has been an upsurge in the number of deaths and infected individuals throughout the world, thereby leading to the World Health Organization declaration of a pandemic. Since no specific therapy is currently available for the same, the present study was aimed to explore the SARS-CoV-2 genome for the identification of immunogenic regions using immunoinformatics approach. A series of computational tools were applied in a systematic way to identify the epitopes that could be utilized in vaccine development. The screened-out epitopes were passed through several immune filters, such as promiscuousity, conservancy, antigenicity, nonallergenicity, population coverage, nonhomologous to human proteins, and affinity with human leukocyte antigen alleles, to screen out the best possible ones. Further, a construct comprising 11 CD4, 12 CD8, 3 B cell, and 3 interferon-γ epitopes, along with an adjuvant ß-defensin, was designed in silico, resulting in the formation of a multiepitope vaccine. The in silico immune simulation and population coverage analysis of the vaccine sequence showed its capacity to elicit cellular, humoral, and innate immune cells and to cover up a worldwide population of more than 97%. Further, the interaction analysis of the vaccine construct with Toll-like receptor 3 (immune receptor) was carried out by docking and dynamics simulations, revealing high affinity, constancy, and pliability between the two. The overall findings suggest that the vaccine may be highly effective, and is therefore required to be tested in the lab settings to evaluate its efficacy.


Assuntos
Vacinas contra COVID-19/imunologia , Epitopos de Linfócito B/imunologia , Epitopos de Linfócito T/imunologia , Genoma Viral , Interferon gama/imunologia , SARS-CoV-2/genética , Antígenos Virais , COVID-19/prevenção & controle , Clonagem Molecular , Epitopos de Linfócito B/genética , Epitopos de Linfócito T/genética , Humanos , Modelos Biológicos , Modelos Moleculares , Simulação de Dinâmica Molecular , Filogenia , Conformação Proteica , Processamento de Proteína Pós-Traducional , Vacinas de Subunidades Antigênicas/imunologia , Proteínas Virais/imunologia
2.
Indian J Pathol Microbiol ; 64(3): 532-534, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34341266

RESUMO

BACKGROUND: Condylomata acuminata, commonly known as genital wart is a sexually transmitted disease caused by Human Papillomavirus (HPV). The positivity of HPV6/11 in condylomata acuminata in western literature varies from 80-90% however, there is a paucity of Indian literature. AIM: The aim of the present study was to determine the role of HPV 6 & 11 in Condylomata acuminata in Indian patients. METHODS: A total of 22 formalin fixed parafilm embedded (FFPE) tissue was collected from the cases of condylomata acuminata which was histologically diagnosed and was used to detect HPV 6 and 11 by PCR. RESULTS: Of these 14/22 patients (63.6%) were positive for HPV 6 or 11; HPV 6 alone in eight (36.3%) and HPV 11 in six (27.2%). CONCLUSION: The high HPV 6 and 11 PCR positivity suggests their definitive role in causation of condylomas cases. This important HPV infection is preventable by prophylactic vaccination.


Assuntos
Condiloma Acuminado/epidemiologia , Condiloma Acuminado/virologia , Papillomavirus Humano 6/patogenicidade , Papillomaviridae/patogenicidade , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Biópsia , Condiloma Acuminado/etnologia , DNA Viral , Feminino , Formaldeído , Papillomavirus Humano 6/genética , Humanos , Índia/epidemiologia , Masculino , Pessoa de Meia-Idade , Papillomaviridae/classificação , Papillomaviridae/genética , Infecções por Papillomavirus/epidemiologia , Infecções por Papillomavirus/virologia , Inclusão em Parafina , Pele/patologia , Pele/virologia , Adulto Jovem
3.
Sci Rep ; 9(1): 2517, 2019 02 21.
Artigo em Inglês | MEDLINE | ID: mdl-30792446

RESUMO

Kaposi's sarcoma-associated herpesvirus (KSHV) responsible for causing Kaposi sarcoma (KS), an opportunistic angioproliferative neoplasm is emerging rapidly. Despite this there is no permanent cure for this disease. The present study was aimed to design a multi-epitope based vaccine targeting the major glycoproteins of KSHV which plays an important role in the virus entry. After the application of rigorous immunoinformatics analysis and several immune filters, the multi-epitope vaccine was constructed, consisting of CD4, CD8 and IFN-γ inducing epitopes. Several physiochemical characteristics, allergenicity and antigenicity of the multi-epitope vaccine were analyzed in order to ensure its safety and immunogenicity. Further, the binding affinity and stability of the vaccine with Toll like receptor -9 (TLR-9) was analyzed by molecular docking and dynamics simulation studies. In addition, an in silico cloning was performed to ensure the expression and translation efficiency of the vaccine, utilizing pET-28a (+) vector. Such T-cell-based immunotherapies which leverage this mechanism could prove their potential against cancer. Further, the authors propose to test the present findings in the lab settings to ensure the safety, immunogenicity and efficacy of the presented vaccine which may help in controlling KSHV infection.


Assuntos
Epitopos de Linfócito B/imunologia , Epitopos de Linfócito T/imunologia , Sarcoma de Kaposi/imunologia , Vacinas de Subunidades Antigênicas/imunologia , Sequência de Aminoácidos/genética , Vacinas Anticâncer/genética , Vacinas Anticâncer/imunologia , Proliferação de Células/genética , Biologia Computacional , Epitopos de Linfócito B/genética , Epitopos de Linfócito T/genética , Glicoproteínas/genética , Glicoproteínas/imunologia , Herpesvirus Humano 8/imunologia , Herpesvirus Humano 8/patogenicidade , Humanos , Simulação de Acoplamento Molecular , Sarcoma de Kaposi/genética , Sarcoma de Kaposi/prevenção & controle , Sarcoma de Kaposi/virologia , Receptor Toll-Like 9/genética , Vacinas de Subunidades Antigênicas/genética
4.
Indian J Med Microbiol ; 37(1): 24-28, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31424006

RESUMO

Introduction: Varicella outbreaks are known to occur in developing nations as vaccine coverage is still low. Material and Methods: In the present study, an institutional outbreak from Chandigarh, India, is reported wherein the utility of non-invasive samples such as saliva and urine was studied for the molecular diagnosis of varicella by conventional polymerase chain reaction (PCR), real-time PCR and real-time loop-mediated isothermal amplification (real-time LAMP). Results: The results of the present study showed that saliva and urine samples can be used for outbreak investigation of varicella compared to varicella-zoster virus DNA in vesicular swab samples with reasonable sensitivity. Conclusion: Thus, molecular techniques may be useful in the early identification of the outbreak and timely isolation, and the treatment of cases can further prevent its spread.


Assuntos
Varicela/diagnóstico , Varicela/epidemiologia , Técnicas de Diagnóstico Molecular/métodos , Saliva/virologia , Urina/virologia , Adolescente , Anticorpos Antivirais/sangue , Varicela/imunologia , Criança , Proteção da Criança , DNA Viral/análise , Surtos de Doenças/estatística & dados numéricos , Feminino , Instalações de Saúde , Herpesvirus Humano 3/genética , Herpesvirus Humano 3/imunologia , Herpesvirus Humano 3/isolamento & purificação , Humanos , Índia/epidemiologia , Masculino , Técnicas de Amplificação de Ácido Nucleico/métodos , Reação em Cadeia da Polimerase
5.
Eur J Drug Metab Pharmacokinet ; 43(5): 607-613, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-29577177

RESUMO

BACKGROUND AND OBJECTIVES: The protective role of vitamin D supplementation has recently been shown to be present in various ocular inflammatory diseases. The oral supplementation of vitamin D may take time to achieve adequate levels in intraocular fluids. Therefore, the present study was performed to understand the ocular pharmacokinetics of 25-hydroxyvitamin D3 (25D3) in aqueous humor after weekly supplementation of 25D3 in rabbits. METHODS: A total of 21 rabbits were fed orally with 25D3 (7.22 µg/kg/week) for 8 weeks and 9th dose was given at the end of 8 weeks. The blood and aqueous humor samples were collected from ear vein and though anterior chamber paracentesis, respectively. The serum and aqueous humor samples were spiked with deuterium labeled internal standard and were extracted using liquid extraction method. Furthermore, the samples were derivatized and 25D3 estimation was performed using ultra performance liquid chromatography-tandem mass spectrometer (UHPLC-MS/MS). RESULTS: The 25D3 supplementation significantly increased the 25D3 levels in serum (78.5 ± 21.6 ng/ml) (mean ± SD) (p < 0.0001) and in aqueous humor (991.3 ± 180.6 pg/ml) (mean ± SD) (p < 0.0001) compared to baseline levels. The maximum concentration was achieved in serum after the 10th hour of supplementation of 1st and 9th dose, while the same was observed at the 24th hour in aqueous humor. CONCLUSION: The oral supplementation of 25D3 was found to significantly increase 25D3 levels in aqueous humor; however, the time required to achieve 25D3 concentration in aqueous humor was higher as compared to that in serum. Therefore, weekly oral supplementation of 25D3 may have a beneficial role in ocular diseases.


Assuntos
Humor Aquoso/metabolismo , Calcifediol/administração & dosagem , Calcifediol/farmacocinética , Cromatografia Líquida de Alta Pressão/métodos , Suplementos Nutricionais , Espectrometria de Massas em Tandem , Administração Oral , Animais , Calcifediol/sangue , Esquema de Medicação , Coelhos
6.
Indian J Med Microbiol ; 36(1): 113-115, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29735838

RESUMO

Human adenovirus (HAdV) is a major cause of viral conjunctivitis. The various serotypes implicated in the causation are 3, 4, 8, 19 and 37. The present study aimed to know the circulating types of HAdV causing acute conjunctivitis in North India. A total of 23 conjunctival swabs were collected from patients with clinically suspected acute viral conjunctivitis during 2014-2015. The HAdV was implicated in the etiology in 65.2% of cases. The sequencing of representative samples using hexon gene suggests the presence of serotype 8 and 4. The serotype eight sequences showed 99%-100% similarity with other Indian strains. The phylogenetic analysis showed that the current circulating serotypes, responsible for conjunctivitis, belonged to epidemic keratoconjunctivitis strains.


Assuntos
Infecções por Adenovirus Humanos/epidemiologia , Adenovírus Humanos/classificação , Adenovírus Humanos/isolamento & purificação , Conjuntivite Viral/epidemiologia , Adenovírus Humanos/genética , Adulto , Sequência de Bases , Conjuntivite Viral/virologia , DNA Viral/genética , Feminino , Genoma Viral , Humanos , Índia/epidemiologia , Masculino , Epidemiologia Molecular , Filogenia , Análise de Sequência de DNA
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA